Federal government-interest patent disclosures for recent top-selling drugs

To provide updated evidence on government-interest patent disclosures in US patents for top-selling small-molecule drugs. IQVIA National Sales Perspectives data identified 300 top-selling drugs, defined by peak 2013-2017 US sales. For the 197 approved through New Drug Applications (NDAs), data were...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical economics p. 1
Main Author Long, Genia
Format Journal Article
LanguageEnglish
Published England 02.12.2019
Subjects
I11
research and development
Prescription drugs
patents
economics
O31
Online AccessGet more information

Cover

Be the first to leave a comment!
You must be logged in first